Peter Slover
Director of Finance/CFO at CONTINEUM THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2024
Profile
Peter T.
Slover is currently the Chief Financial & Accounting Officer at Contineum Therapeutics, Inc. Prior to his current position, he held the role of Chief Financial Officer, CAO & SVP-Operations at Anadys Pharmaceuticals, Inc. from 2009 to 2010.
He also worked as an Auditor at KPMG LLP from 1997 to 2004.
From 2013 to 2020, he served as the Chief Financial & Accounting Officer at Sophiris Bio, Inc. Mr. Slover obtained his undergraduate degree from Shippensburg University of Pennsylvania in 1997.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/05/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Peter Slover active positions
| Companies | Position | Start |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Director of Finance/CFO | 01/09/2020 |
Former positions of Peter Slover
| Companies | Position | End |
|---|---|---|
| SOPHIRIS BIO | Director of Finance/CFO | 01/05/2020 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Director of Finance/CFO | - |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2004 |
Training of Peter Slover
| Shippensburg University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Peter Slover
